These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34163888)

  • 1. Click activated protodrugs against cancer increase the therapeutic potential of chemotherapy through local capture and activation.
    Wu K; Yee NA; Srinivasan S; Mahmoodi A; Zakharian M; Mejia Oneto JM; Royzen M
    Chem Sci; 2021 Jan; 12(4):1259-1271. PubMed ID: 34163888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species.
    Srinivasan S; Yee NA; Zakharian M; Alečković M; Mahmoodi A; Nguyen TH; Mejía Oneto JM
    bioRxiv; 2023 Mar; ():. PubMed ID: 37034617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents.
    McFarland JM; Alečković M; Coricor G; Srinivasan S; Tso M; Lee J; Nguyen TH; Mejía Oneto JM
    ACS Cent Sci; 2023 Jul; 9(7):1400-1408. PubMed ID: 37521794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected & Non-injected Lesions.
    Srinivasan S; Yee NA; Wu K; Zakharian M; Mahmoodi A; Royzen M; Oneto JMM
    Adv Ther (Weinh); 2021 Mar; 4(3):. PubMed ID: 33869738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrazine-trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body.
    Tomarchio EG; Turnaturi R; Saccullo E; Patamia V; Floresta G; Zagni C; Rescifina A
    Bioorg Chem; 2024 Sep; 150():107573. PubMed ID: 38905885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-Demand Drug Release from Click-Refillable Drug Depots.
    Palvai S; Moody CT; Pandit S; Brudno Y
    Mol Pharm; 2021 Oct; 18(10):3920-3925. PubMed ID: 34494844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabody Pretargeting with Click Chemistry In Vivo.
    van Duijnhoven SM; Rossin R; van den Bosch SM; Wheatcroft MP; Hudson PJ; Robillard MS
    J Nucl Med; 2015 Sep; 56(9):1422-8. PubMed ID: 26159589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
    Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
    MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.
    Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS
    Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Binding of Liposomal Nanoparticles through Inverse Electron-Demand Diels-Alder Click Chemistry.
    Brand C; Iacono P; Pérez-Medina C; Mulder WJM; Kircher MF; Reiner T
    ChemistryOpen; 2017 Oct; 6(5):615-619. PubMed ID: 29046855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Pretargeting Based on Cysteine-Selective Antibody Modification with IEDDA Bioorthogonal Handles for Click Chemistry.
    Ferreira VFC; Oliveira BL; D'Onofrio A; Farinha CM; Gano L; Paulo A; Bernardes GJL; Mendes F
    Bioconjug Chem; 2021 Jan; 32(1):121-132. PubMed ID: 33295756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrazine Carbon Nanotubes for Pretargeted In Vivo "Click-to-Release" Bioorthogonal Tumour Imaging.
    Li H; Conde J; Guerreiro A; Bernardes GJL
    Angew Chem Int Ed Engl; 2020 Sep; 59(37):16023-16032. PubMed ID: 32558207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines.
    Bredack C; Edelmann MR; Borroni E; Gobbi LC; Honer M
    Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Targeted Click-to-Release Activation of the Last-Resort Antibiotic Colistin Reduces its Renal Cell Toxicity.
    Charoenpattarapreeda J; Tegge W; Xu C; Harmrolfs K; Hinkelmann B; Wullenkord H; Hotop SK; Beutling U; Rox K; Broenstrup M
    Angew Chem Int Ed Engl; 2024 Aug; ():e202408360. PubMed ID: 39113573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
    Houghton JL; Membreno R; Abdel-Atti D; Cunanan KM; Carlin S; Scholz WW; Zanzonico PB; Lewis JS; Zeglis BM
    Mol Cancer Ther; 2017 Jan; 16(1):124-133. PubMed ID: 28062708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Radionuclide Theranostic Pretargeting.
    Keinänen O; Brennan JM; Membreno R; Fung K; Gangangari K; Dayts EJ; Williams CJ; Zeglis BM
    Mol Pharm; 2019 Oct; 16(10):4416-4421. PubMed ID: 31483993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretargeted PET of Osteodestructive Lesions in Dogs.
    Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
    Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy.
    Membreno R; Keinänen OM; Cook BE; Tully KM; Fung KC; Lewis JS; Zeglis BM
    Mol Pharm; 2019 May; 16(5):2259-2263. PubMed ID: 30912951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.